Cutler Group LP Biomarin Pharmaceutical Inc Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$76.22 - $98.51 $320,124 - $413,742	4,200 New	4,200 $20,000
Q4 2022 Feb 07, 2023	SELL	$80.93 - $108.63 $80,930 - $108,630	-1,000 Reduced 71.43%	400 $0
Q3 2022 Oct 25, 2022	SELL	$82.16 - $96.94 $90,376 - $106,634	-1,100 Reduced 44.0%	1,400 $5,000
Q2 2022 Aug 04, 2022	SELL	$71.48 - $86.85 $114,368 - $138,960	-1,600 Reduced 39.02%	2,500 $7,000
Q1 2022 Apr 14, 2022	BUY	$74.28 - $92.69 $7,428 - $9,269	100 Added 2.5%	4,100 $17,000
Q4 2021 Jan 18, 2022	BUY	$71.72 - $91.47 $200,816 - $256,116	2,800 Added 233.33%	4,000 $6,000
Q2 2021 Jul 19, 2021	SELL	$75.51 - $84.79 $1.56 Million - $1.75 Million	-20,600 Reduced 94.5%	1,200 $5,000
Q4 2020 Jan 21, 2021	BUY	$72.61 - $90.2 $1.37 Million - $1.7 Million	18,900 Added 651.72%	21,800 $8,000
Q3 2020 Oct 27, 2020	SELL	$71.87 - $131.03 $114,992 - $209,648	-1,600 Reduced 35.56%	2,900 $8,000
Q1 2020 May 07, 2020	SELL	$71.37 - $96.85 $178,425 - $242,125	-2,500 Reduced 35.71%	4,500 $25,000
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $32,134 - $43,185	-500 Reduced 6.67%	7,000 $24,000
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $361,575 - $422,550	4,500 Added 150.0%	7,500 $17,000
Q1 2019 May 10, 2019	SELL	$84.2 - $98.62 $3.29 Million - $3.86 Million	-39,100 Reduced 92.87%	3,000 $21,000
Q4 2018 Feb 05, 2019	BUY	$80.14 - $106.07 $2.5 Million - $3.31 Million	31,200 Added 286.24%	42,100 $295,000
Q3 2018 Nov 07, 2018	BUY	$93.92 - $105.72 $291,152 - $327,732	3,100 Added 39.74%	10,900 $26,000
Q2 2018 Aug 10, 2018	SELL	$76.01 - $99.03 $174,823 - $227,769	-2,300 Reduced 22.77%	7,800 $24,000
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $2 Million - $2.39 Million	-25,800 Reduced 71.87%	10,100 $38,000
Q4 2017 Jan 17, 2018	BUY	$80.76 - $95.13 $436,104 - $513,702	5,400 Added 17.7%	35,900 $80,000
Q3 2017 Oct 17, 2017	BUY	$80.6 - $94.95 $2.46 Million - $2.9 Million	30,500	30,500 $87,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account